Ontology highlight
ABSTRACT:
SUBMITTER: Fu Y
PROVIDER: S-EPMC8298272 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
Fu Yuyin Y Peng Yujia Y Zhao Shengyan S Mou Jun J Zeng Lishi L Jiang Xiaohua X Yang Chengli C Huang Cheng C Li Yuyan Y Lu Yin Y Wu Mengdan M Yang Yanfang Y Kong Ting T Lai Qinhuai Q Wu Yangping Y Yao Yuqin Y Wang Yuxi Y Gou Lantu L Yang Jinliang J
Frontiers in cell and developmental biology 20210708
Immune checkpoint inhibitors have achieved unprecedented success in cancer immunotherapy. However, the overall response rate to immune checkpoint inhibitor therapy for many cancers is only between 20 and 40%, and even less for colorectal cancer (CRC) patients. Thus, there is an urgent need to develop an efficient immunotherapeutic strategy for CRC. Here, we developed a novel CRC combination therapy consisting of a multiple receptor tyrosine kinase inhibitor (Foretinib) and anti-PD-1 antibody. Th ...[more]